Rockville's DrFirst bulks up with acquisition of Arizona health tech startup
The company said it's buying developed software that helps speed patients' access to specialty drugs. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 18, 2024 Category: Biotechnology Authors: Sara Gilgore Source Type: news

23andMe going private
From the Silicon Valley Business Journal. Anne W ójcicki is taking 23andMe Holdings Co. (NASDAQ: ME) private as the company's share price dropped to 36 cents this week, a collapse from a high of $6 billion in 2021.  Wójcicki filed the request Wednesday with the U.S Securities and Exchange Commission stating that on "April 13, 2024, (she) not ified members of the special committee of the Board that she is considering making a proposal to acquire the Issuer in a potential go-private transaction"… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 18, 2024 Category: Biotechnology Authors: Anthony Duignan-Cabrera Source Type: news

CVS urges ‘no’ vote on workers' rights assessment
CVS says the cost of conducting such an assessment is “unwarranted” and “would likely run into seven figures” given CVS’s roughly 9,000 U.S. store locations. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 18, 2024 Category: Biotechnology Authors: Mary Serreze Source Type: news

Cigna wins $6M judgment against South Florida health care provider
Cigna accused the health care provider of fraudulent billing. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 18, 2024 Category: Biotechnology Authors: Brian Bandell Source Type: news

Middle East crisis escalation may hurt pharma exports
While exports have not been affected so far, the next few days are crucial because, if there is serious escalation in the conflict, it could impact the whole Middle East and North Africa (MENA) region. Many Indian pharma companies have a significant presence in the region. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 18, 2024 Category: Pharmaceuticals Source Type: news

Solesis names new CEO to lead aggressive growth plans
Solesis has 450 employees in Pennsylvania and North Carolina. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 18, 2024 Category: Biotechnology Authors: John George Source Type: news

Ascension St. Vincent ’s names new leaders for area hospitals
Kevin Rinks and Bryan Walrath selected for the positions. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 18, 2024 Category: Biotechnology Authors: Stuart Korfhage Source Type: news

CDCSO issues distribution guidelines for pharma products in market to curb substandard medicines
The Central Drugs Standard Control Organisation (CDSCO) has released draft guidelines on good distribution practices to prevent the introduction of spurious, adulterated, and sub-standard pharmaceutical products in the market. The guidelines are in line with the WHO Technical Report Series on good storage and distribution practices for such products. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 18, 2024 Category: Pharmaceuticals Source Type: news

Reimagining the Translation from Biologics Discovery to Development, Upcoming Webinar Hosted by Xtalks
In this free webinar, gain insights into the most effective tools, technologies and strategies for biologics discovery and development. Attendees will learn about stable bulk cultures (SBC)-based platforms, which represent a paradigm shift for start-up biotech companies and enable them to... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 18, 2024 Category: Pharmaceuticals Tags: FVT Source Type: news

Eli Lilly subsidiary ends lucrative collaboration with Durham biotech
The deal included milestone payments up to nearly $400 million for Precision BioSciences. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 18, 2024 Category: Biotechnology Authors: Zac Ezzone Source Type: news

Organ regeneration startup names veteran CEO as new leader
The new chief executive of Morphoceuticals will chart the company's path into a relatively new and unknown field: Organ regeneration and tissue repair. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 18, 2024 Category: Biotechnology Authors: Hannah Green Source Type: news

Petri Dish: Non-viral vector startup launch; Foghorn ’s new CFO
In this week ’s Petri Dish we’ll take a look at a new Cambridge company founded by gene-editing experts that emerged with some big funding, as well as Foghorn Therapeutics’ new CFO and the awardees of $2.8 million in women's health funding. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 18, 2024 Category: Biotechnology Authors: Hannah Green Source Type: news

New renderings released of OhioHealth Grant Medical Center's downtown expansion
OhioHealth Corp. could start the second phase of its expansion to downtown's Grant Medical Center as early as next spring. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 18, 2024 Category: Biotechnology Authors: Carrie Ghose Source Type: news

Govt mulls allowing sale of common medicines in general stores
India's committee, under Atul Goel's leadership, is pioneering the development of guidelines for over-the-counter medicines to improve accessibility. This initiative marks a significant step towards streamlining non-prescription drug regulations. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 18, 2024 Category: Pharmaceuticals Source Type: news

Complaint filed against Natco Pharma in US by Fresenius Kabi
Natco Pharma faces a legal complaint from Fresenius Kabi in the US District Court regarding the marketing of Diazepam injection prefilled syringe. Fresenius Kabi USA, LLC and Fresenius Kabi Deutschland GmbH filed the complaint against Natco Pharma USA LLC (formerly Dash Pharmaceuticals LLC). (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 18, 2024 Category: Pharmaceuticals Source Type: news